STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

ISG to Publish Report on Life Sciences Digital Services

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Information Services Group (NASDAQ: III) has launched a study assessing digital service providers for the life sciences sector. The findings will be published in the ISG Provider Lens™ report, titled Life Sciences Digital Services 2022, due in February 2023. The report will focus on pivotal areas like clinical development, patient engagement, and supply chain transformation. It aims to aid enterprise buyers in evaluating vendor relationships and adapting to changes imposed by the pandemic and technological advancements.

Positive
  • Launch of a comprehensive study on digital services for life sciences companies, enhancing its market visibility.
  • The forthcoming report will assist enterprises in reevaluating vendor relationships, fostering strategic decision-making.
Negative
  • The ongoing pandemic and supply chain challenges may indicate a volatile market environment for potential service providers.

Upcoming ISG Provider Lens™ report will evaluate service providers enabling digital transformation by life sciences companies for innovation, patient engagement

STAMFORD, Conn.--(BUSINESS WIRE)-- Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, has launched a research study examining providers of digital services to the life sciences industry.

The study results will be published in a comprehensive ISG Provider Lens™ report, called Life Sciences Digital Services 2022, scheduled to be released in February 2023. The report will cover companies offering services including transformation of clinical development, patient engagement, manufacturing supply chain, regulatory affairs and MedTech product development.

Enterprise buyers will be able to use information from the report to evaluate their current vendor relationships, potential new engagements and available offerings, while ISG advisors use the information to recommend providers to the firm’s buy-side clients.

Life sciences companies are changing their business models to deal with new resource constraints stemming from the COVID-19 pandemic and supply-chain and workforce disruptions. Traditionally conservative industry leaders are pursuing large-scale innovation to keep growing in a fast-changing market. Doing this efficiently requires new, AI-powered solutions that require rapid investment.

Service providers are increasingly important to life sciences companies that seek support to address changing technologies, new ways of working, and rising customer expectations.

“Life sciences companies are not just outsourcing established roles to service providers anymore,” said Jan Erik Aase, partner and global leader, ISG Provider Lens Research. “Providers are becoming strategic partners and delivering expert advice on automation, cybersecurity and other technologies.”

ISG has distributed surveys to approximately 90 life sciences digital service providers. Working in collaboration with ISG’s global advisors, the research team will produce five quadrants representing the services the typical life sciences enterprise is buying, based on ISG’s experience working with its clients. The five quadrants are:

  • Clinical Development Digital Transformation, evaluating service providers that help companies develop products during all clinical phases. These providers deliver technologies to improve efficiency, management, data analysis, regulatory reporting and other functions.
  • Patient Engagement Digital Transformation, assessing providers of supporting processes and platforms that allow life sciences companies to engage directly with patients. They help clients use remote monitoring and other technologies in more patient-centric services to improve products and patient outcomes.
  • Manufacturing Supply Chain Digital Transformation, covering providers that help companies overcome ongoing supply-chain challenges, including restrictions on movement and changes in reporting requirements. They often using automation and AI to improve supply-chain visibility and production forecasts.
  • PVG and Regulatory Affairs Digital Transformation, evaluating service providers that support patient safety monitoring, pharmacovigilance (PVG) and reporting compliance, helping life sciences companies deliver high-quality products under increasing scrutiny by regulatory agencies and consumer watchdog groups.
  • MedTech Digital Transformation, assessing service providers that help MedTech vendors use emerging technologies such as IoT, mobile enablement and advanced analytics to digitize product development, engineering, production and logistics.

A report generated from the study will cover the global life sciences digital transformation market and examine available products and services. ISG analysts Rainer Suletzki, Frances Grote and Sandya Kattimani will serve as authors of the report.

A list of identified providers and vendors and further details on the study are available in this digital brochure. Companies not listed as life sciences digital service providers can contact ISG and ask to be included in the study.

All 2022 ISG Provider Lens™ evaluations now feature new and expanded customer experience (CX) data that measures actual enterprise experience with specific provider services and solutions, based on ISG’s continuous CX research. Enterprise customers wishing to share their experience about a specific provider or vendor are encouraged to register here to receive a personalized survey URL. Participants will receive a copy of this report in return for their feedback.

About ISG Provider Lens™ Research

The ISG Provider Lens™ Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage.

A companion research series, the ISG Provider Lens Archetype reports, offer a first-of-its-kind evaluation of providers from the perspective of specific buyer types.

About ISG

ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 800 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com.

Press:

Will Thoretz, ISG

+1 203 517 3119

will.thoretz@isg-one.com

Julianna Sheridan, Matter Communications for ISG

+1 978-518-4520

isg@matternow.com

Source: Information Services Group, Inc.

FAQ

What is the ISG Provider Lens report on digital services for life sciences companies?

The ISG Provider Lens report evaluates service providers enabling digital transformation in the life sciences sector, focusing on various aspects like clinical development and patient engagement.

When will the Life Sciences Digital Services 2022 report be released?

The report is scheduled for release in February 2023.

How can enterprise buyers benefit from the ISG Provider Lens report?

Enterprise buyers can use the report to assess their vendor relationships and explore new service offerings tailored to the evolving life sciences landscape.

What key areas will the ISG Provider Lens report cover?

The report will cover five quadrants including clinical development, patient engagement, manufacturing supply chain, regulatory affairs, and MedTech digital transformation.

What impact does the COVID-19 pandemic have on life sciences companies?

The pandemic has forced life sciences companies to adapt their business models due to resource constraints and supply chain disruptions, driving the need for digital transformation.

Information Services Group, Inc.

NASDAQ:III

III Rankings

III Latest News

III Stock Data

179.85M
35.05M
28.57%
60.91%
0.26%
Information Technology Services
Services-management Consulting Services
Link
United States of America
STAMFORD